Phosphatidylinositol-3-Kinase/Akt Signaling Pathway and Kidney Cancer, and the Therapeutic Potential of Phosphatidylinositol-3-Kinase/Akt Inhibitors EDITORIAL COMMENT

被引：0
|
作者：
Oya, Mototsugu [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan
来源：
JOURNAL OF UROLOGY | 2009年 / 182卷 / 06期
关键词：
D O I：
10.1016/j.juro.2009.08.136
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2577 / 2577
页数：1
相关论文
共 50 条
  • [1] Phosphatidylinositol-3-Kinase/Akt Signaling Pathway and Kidney Cancer, and the Therapeutic Potential of Phosphatidylinositol-3-Kinase/Akt Inhibitors
    Porta, Camillo
    Figlin, Robert A.
    JOURNAL OF UROLOGY, 2009, 182 (06) : 2569 - 2577
  • [2] Practicalities of drugging the phosphatidylinositol-3-kinase/Akt cell survival signaling pathway
    Powis, Garth
    Ihle, Nathan
    Kirkpatrick, D. Lynn
    CLINICAL CANCER RESEARCH, 2006, 12 (10) : 2964 - 2966
  • [3] Inhibitors of phosphatidylinositol-3-kinase in cancer therapy
    Ihle, Nathan T.
    Powis, Garth
    MOLECULAR ASPECTS OF MEDICINE, 2010, 31 (02) : 135 - 144
  • [4] Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma
    Aziz, Saadia A.
    Davies, Michael
    Pick, Elah
    Zito, Christopher
    Jilaveanu, Lucia
    Camp, Robert L.
    Rimm, David L.
    Kluger, Yuval
    Kluger, Harriet M.
    CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3029 - 3036
  • [5] A role for the phosphatidylinositol-3-kinase pathway in preconditioning
    Murphy, E
    Tong, HY
    Steenbergen, C
    MYOCARDIAL ISCHEMIA AND PRECONDITIONING, 2003, 6 : 275 - 282
  • [6] Targeting phosphatidylinositol-3-kinase
    Gurwitz, D
    DRUG DISCOVERY TODAY, 1999, 4 (02) : 96 - 96
  • [7] Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma
    Trautmann, Marcel
    Cyra, Magdalene
    Isfort, Ilka
    Jeiler, Birte
    Krueger, Arne
    Gruenewald, Inga
    Steinestel, Konrad
    Altvater, Bianca
    Rossig, Claudia
    Hafner, Susanne
    Simmet, Thomas
    Becker, Jessica
    Amana, Pierre
    Wardelmann, Eva
    Huss, Sebastian
    Hartmann, Wolfgang
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (04) : 834 - 844
  • [8] NOVEL QUINONE ANTIPROLIFERATIVE INHIBITORS OF PHOSPHATIDYLINOSITOL-3-KINASE
    FREW, T
    POWIS, G
    BERGGREN, M
    GALLEGOS, A
    ABRAHAM, RT
    ASHENDEL, CL
    ZALKOW, LH
    HUDSON, C
    GRUSZECKAKOWALIK, E
    BURGESS, EM
    BENEDETTIDOCTOROVICH, V
    KERRIGAN, JE
    LAMBROPOULOS, J
    MERRIMAN, R
    BONJOUKLIAN, R
    ANTI-CANCER DRUG DESIGN, 1995, 10 (04): : 347 - 359
  • [9] High prevalence and mutual exclusivity of genetic alterations in the phosphatidylinositol-3-kinase/Akt pathway in thyroid tumors
    Wang, Yangang
    Hou, Peng
    Yu, Hongyu
    Wang, Wei
    Ji, Meiju
    Zhao, Shihua
    Yan, Shengli
    Sun, Xianlu
    Liu, Dingxie
    Shi, Bingyin
    Zhu, Guangwu
    Condouris, Stephen
    Xing, Mingzhao
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (06) : 2387 - 2390
  • [10] Thyroid hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/AKT pathway
    Krueger, Martina
    Sachse, Christine
    Zimmermann, Wolfram H.
    Eschenhagen, Thomas
    Klede, Stefanie
    Linke, Wolfgang A.
    CIRCULATION RESEARCH, 2008, 102 (04) : 439 - 447
12345